• Ruxolitinib

    Ruxolitinib

    Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US)
    Ruxolitinib Myelofibrosis Novartis Jul. 6, 2024
  • Relugolix

    Relugolix

    Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US)
    Relugolix Khansara ya Prostatic Takeda ndi ASKA Januware 24, 2024
  • Rimegepant

    Rimegepant

    Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US)
    Rimegepant Mutu wa Migraine Biohaven Feb. 22, 2031

     

  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 Antineoplastic M'nyumba      
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US)
    Ribociclib 1374639-75-4 HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
    Mankhwala
    Jun. 27, 2028
  • Rivaroxaban

    Rivaroxaban

    Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP
    Rivaroxaban Anticoagulant M'nyumba TDP    
  • Rosuvastatin Calcium

    Rosuvastatin kashiamu

    Dzina la API Chizindikiro Kufotokozera US DMF EU DMF CEP
    Rosuvastatin kashiamu Hypercholesterolemia M'nyumba / CEP 20705 CEP2015-240